Boc-N-Me-allo-Ile-OH

Boc-N-Me-allo-Ile-OH is an N-Boc protected, N-methylated allo-Isoleucine amino acid derivative designed for peptide and peptidomimetic synthesis where backbone substitution and stereochemical control are important. The N-methyl group constrains amide formation and is commonly used to modulate conformational preferences in designed peptides, while the Boc group provides an acid-stable handle for downstream coupling strategies. Its isoleucine-derived side chain supports incorporation into peptide sequences and medicinal chemistry intermediates targeting structure-activity relationship studies.

1. Peptidomimetic Building Block

Boc-N-Me-allo-Ile-OH is used by peptide chemistry groups to introduce an N-methylated allo-Ile residue into peptidomimetic scaffolds, enabling systematic evaluation of how backbone N-methylation and stereochemistry affect conformation and sequence behavior. Researchers developing constrained or protease-resistant peptide analogs often select N-methyl amino acid building blocks to tune amide hydrogen-bonding patterns and local geometry within the target sequence. The Boc-protected form supports its use as a defined, single-residue input for custom peptide assembly workflows, where consistent stereochemical identity and controlled backbone substitution are required for reliable structure-property comparisons.

2. Solid-Phase Peptide Synthesis

Boc-N-Me-allo-Ile-OH is employed in solid-phase peptide synthesis workflows where defined amino acid derivatives are required for stepwise chain construction and sequence diversification. Peptide synthesis teams use N-methylated amino acid inputs to generate peptide variants that differ at specific backbone positions, supporting library-style preparation of analogs for chemical biology and medicinal chemistry screening. The Boc protection pattern provides a practical starting point for coupling strategies that require a protected amino acid building block rather than a free amino acid, helping maintain sequence integrity during assembly and enabling reproducible incorporation of the allo-Ile stereochemical configuration.

3. Medicinal Chemistry SAR Intermediates

Boc-N-Me-allo-Ile-OH serves as a pharmaceutical intermediate for medicinal chemistry programs that prepare modified peptide leads and non-natural peptide analogs for structure-activity relationship studies. Medicinal chemistry researchers incorporate N-methylated amino acid residues to probe how backbone modifications influence properties such as conformational distribution and functional presentation of side chains within a bioactive pharmacophore. The allo-Ile stereochemical specification supports SAR campaigns that require precise stereochemical control at the residue level, particularly when comparing closely related analog series where both stereochemistry and N-substitution differ.

4. Conformational Control Studies

Boc-N-Me-allo-Ile-OH is also used in chemical biology and physical organic research to generate peptide fragments that probe conformational effects of N-methylation and allo stereochemistry. Teams studying structure-property relationships in model peptides rely on well-defined residue building blocks to produce comparable constructs where the only intentional variables are the backbone substitution pattern and stereochemical configuration. This makes the derivative valuable for downstream characterization workflows such as analytical profiling of peptide conformers, stability comparisons across designed variants, and interpretation of how N-methyl amide formation changes intramolecular interactions.

1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling